216 related articles for article (PubMed ID: 23686836)
1. CXCR4-targeted therapy inhibits VEGF expression and chondrosarcoma angiogenesis and metastasis.
Sun X; Charbonneau C; Wei L; Yang W; Chen Q; Terek RM
Mol Cancer Ther; 2013 Jul; 12(7):1163-70. PubMed ID: 23686836
[TBL] [Abstract][Full Text] [Related]
2. CXCR4/SDF1 mediate hypoxia induced chondrosarcoma cell invasion through ERK signaling and increased MMP1 expression.
Sun X; Wei L; Chen Q; Terek RM
Mol Cancer; 2010 Jan; 9():17. PubMed ID: 20102637
[TBL] [Abstract][Full Text] [Related]
3. Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers.
Katkoori VR; Basson MD; Bond VC; Manne U; Bumpers HL
Oncotarget; 2015 Sep; 6(29):27763-77. PubMed ID: 26318034
[TBL] [Abstract][Full Text] [Related]
4. Endothelin-1 promotes vascular endothelial growth factor-dependent angiogenesis in human chondrosarcoma cells.
Wu MH; Huang CY; Lin JA; Wang SW; Peng CY; Cheng HC; Tang CH
Oncogene; 2014 Mar; 33(13):1725-35. PubMed ID: 23584483
[TBL] [Abstract][Full Text] [Related]
5. CCL5 promotes VEGF-dependent angiogenesis by down-regulating miR-200b through PI3K/Akt signaling pathway in human chondrosarcoma cells.
Liu GT; Chen HT; Tsou HK; Tan TW; Fong YC; Chen PC; Yang WH; Wang SW; Chen JC; Tang CH
Oncotarget; 2014 Nov; 5(21):10718-31. PubMed ID: 25301739
[TBL] [Abstract][Full Text] [Related]
6. CXCR4-mediated osteosarcoma growth and pulmonary metastasis is promoted by mesenchymal stem cells through VEGF.
Zhang P; Dong L; Yan K; Long H; Yang TT; Dong MQ; Zhou Y; Fan QY; Ma BA
Oncol Rep; 2013 Oct; 30(4):1753-61. PubMed ID: 23863999
[TBL] [Abstract][Full Text] [Related]
7. miR-181a Targets RGS16 to Promote Chondrosarcoma Growth, Angiogenesis, and Metastasis.
Sun X; Charbonneau C; Wei L; Chen Q; Terek RM
Mol Cancer Res; 2015 Sep; 13(9):1347-57. PubMed ID: 26013170
[TBL] [Abstract][Full Text] [Related]
8. The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling.
Ping YF; Yao XH; Jiang JY; Zhao LT; Yu SC; Jiang T; Lin MC; Chen JH; Wang B; Zhang R; Cui YH; Qian C; Wang Jm; Bian XW
J Pathol; 2011 Jul; 224(3):344-54. PubMed ID: 21618540
[TBL] [Abstract][Full Text] [Related]
9. The CXCL12/CXCR7 signalling axis promotes proliferation and metastasis in cervical cancer.
Xu L; Li C; Hua F; Liu X
Med Oncol; 2021 Apr; 38(5):58. PubMed ID: 33847822
[TBL] [Abstract][Full Text] [Related]
10. Delivery of siRNA Using CXCR4-targeted Nanoparticles Modulates Tumor Microenvironment and Achieves a Potent Antitumor Response in Liver Cancer.
Liu JY; Chiang T; Liu CH; Chern GG; Lin TT; Gao DY; Chen Y
Mol Ther; 2015 Nov; 23(11):1772-1782. PubMed ID: 26278330
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA regulates vascular endothelial growth factor expression in chondrosarcoma cells.
Sun X; Wei L; Chen Q; Terek RM
Clin Orthop Relat Res; 2015 Mar; 473(3):907-13. PubMed ID: 25106798
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of CXCR4 activity with AMD3100 decreases invasion of human colorectal cancer cells in vitro.
Li JK; Yu L; Shen Y; Zhou LS; Wang YC; Zhang JH
World J Gastroenterol; 2008 Apr; 14(15):2308-13. PubMed ID: 18416455
[TBL] [Abstract][Full Text] [Related]
13. The CXCR4 antagonist AMD3100 suppresses hypoxia-mediated growth hormone production in GH3 rat pituitary adenoma cells.
Yoshida D; Koketshu K; Nomura R; Teramoto A
J Neurooncol; 2010 Oct; 100(1):51-64. PubMed ID: 20309720
[TBL] [Abstract][Full Text] [Related]
14. CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway.
Liang Z; Brooks J; Willard M; Liang K; Yoon Y; Kang S; Shim H
Biochem Biophys Res Commun; 2007 Aug; 359(3):716-22. PubMed ID: 17559806
[TBL] [Abstract][Full Text] [Related]
15. Basic fibroblast growth factor induces VEGF expression in chondrosarcoma cells and subsequently promotes endothelial progenitor cell-primed angiogenesis.
Tzeng HE; Chen PC; Lin KW; Lin CY; Tsai CH; Han SM; Teng CL; Hwang WL; Wang SW; Tang CH
Clin Sci (Lond); 2015 Jul; 129(2):147-58. PubMed ID: 25735814
[TBL] [Abstract][Full Text] [Related]
16. AMD3100 inhibits epithelial-mesenchymal transition, cell invasion, and metastasis in the liver and the lung through blocking the SDF-1α/CXCR4 signaling pathway in prostate cancer.
Zhu WB; Zhao ZF; Zhou X
J Cell Physiol; 2019 Jul; 234(7):11746-11759. PubMed ID: 30537000
[TBL] [Abstract][Full Text] [Related]
17. miR-622 inhibits angiogenesis by suppressing the CXCR4-VEGFA axis in colorectal cancer.
Fang Y; Sun B; Wang J; Wang Y
Gene; 2019 May; 699():37-42. PubMed ID: 30851425
[TBL] [Abstract][Full Text] [Related]
18. RNAi targeting CXCR4 inhibits proliferation and invasion of esophageal carcinoma cells.
Wang T; Mi Y; Pian L; Gao P; Xu H; Zheng Y; Xuan X
Diagn Pathol; 2013 Jun; 8():104. PubMed ID: 23800042
[TBL] [Abstract][Full Text] [Related]
19. Resistin facilitates VEGF-A-dependent angiogenesis by inhibiting miR-16-5p in human chondrosarcoma cells.
Chen SS; Tang CH; Chie MJ; Tsai CH; Fong YC; Lu YC; Chen WC; Lai CT; Wei CY; Tai HC; Chou WY; Wang SW
Cell Death Dis; 2019 Jan; 10(1):31. PubMed ID: 30631040
[TBL] [Abstract][Full Text] [Related]
20. C-X-C motif chemokine receptor 4 promotes tumor angiogenesis in gastric cancer via activation of JAK2/STAT3.
Zhang Q; Xu F; Shi Y; Chen YW; Wang HP; Yu X; Li Y
Cell Biol Int; 2017 Aug; 41(8):854-862. PubMed ID: 28544312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
